These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35385014)

  • 1. [Trends in drugs usage for COVID-19 during the first wave of the pandemic in a hospital in Lima, Peru].
    Castro NE; García DR; Rivera MT; Rondán-Guerrero P; García-Rojas F; Taype-Rondan A
    Rev Peru Med Exp Salud Publica; 2021; 38(4):608-614. PubMed ID: 35385014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between prehospital medication and fatal outcomes in a cohort of hospitalized patients due to coronavirus disease-2019 in a referral hospital in Peru.
    Caira-Chuquineyra B; Fernandez-Guzman D; Alvarez-Arias PM; Zarate-Curi ÁA; Herrera-Añazco P; Benites-Zapata VA
    Travel Med Infect Dis; 2022; 50():102472. PubMed ID: 36257588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
    Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
    Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication use in pediatric patients with covid-19 hospitalized in a referral hospital in Lima, Peru, 2020 - 2022.
    Luna-Vilchez M; Mejia JR; Ortiz-Benique ZN; Santiago-Abal M; Taype-Rondan A
    Rev Peru Med Exp Salud Publica; 2023; 40(1):73-78. PubMed ID: 37377240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive strategy for the early treatment of COVID-19 with azithromycin/hydroxychloroquine and/or corticosteroids: Results of a retrospective observational study in the French overseas department of Réunion Island.
    Dubernet A; Larsen K; Masse L; Allyn J; Foch E; Bruneau L; Maillot A; Lagrange-Xelot M; Thomas V; Jaffar-Bandjee MC; Gauzere L; Raffray L; Borsu K; Dibernardo S; Renaud S; André M; Moreau D; Jabot J; Coolen-Allou N; Allou N
    J Glob Antimicrob Resist; 2020 Dec; 23():1-3. PubMed ID: 32828896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
    Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A
    Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient prescription patterns of COVID-19 drugs in the metropolitan area of Mexico City.
    Fuentes-Gonzalez MF; Ordinola Navarro A; Carmona-Aguilera Z; Hernández-Jimenez CA; Benitez-Altamirano GM; Beltran-Ontiveros LD; Lopez-Vejar C; Ramirez-Hinojosa JP; Vera-Lastra O; Lopez Luis BA
    Fam Pract; 2022 May; 39(3):515-518. PubMed ID: 34910137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 in pediatric cancer patients in a resource-limited setting: National data from Peru.
    Montoya J; Ugaz C; Alarcon S; Maradiegue E; García J; Díaz R; Zapata A; Chávez S; Morales R; Ordoñez K; Hernandez E; Reaño R; Gutierrez C; Vargas MP; Sanchez K; Valdiviezo C; Maza I; Rojas N; Moore C; León E; Vásquez L
    Pediatr Blood Cancer; 2021 Feb; 68(2):e28610. PubMed ID: 32779840
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of adverse events to hydroxychloroquine, ivermectin, azithromycin and tocilizumab in patients hospitalized due to COVID-19 in a Peruvian Social Health Insurance hospital.
    Rodríguez-Tanta LY; Cachay Rojas E; Fiestas Saldarriaga F; Alva Lozada G; Fernández-Rojas P; Delgado-Escalante R
    Rev Peru Med Exp Salud Publica; 2023; 40(1):16-24. PubMed ID: 37377231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of ivermectin and factors associated with the prevention and/or treatment of COVID-19: a cross-sectional online survey in the province of Chincha, Peru.
    Salvador-Carrillo J; Campos-Loza L; Guillen-Carbajal D; Osada J; Zevallos A; Torres-Roman JS
    F1000Res; 2023; 12():149. PubMed ID: 38178941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 treatment combinations and associations with mortality in a large multi-site healthcare system.
    Coppock D; Baram M; Chang AM; Henwood P; Kubey A; Summer R; Zurlo J; Li M; Hess B
    PLoS One; 2021; 16(6):e0252591. PubMed ID: 34115801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sales of "COVID kit" drugs and adverse drug reactions reported by the Brazilian Health Regulatory Agency.
    Hentschke-Lopes M; Botton MR; Borges P; Freitas M; Mancuso ACB; Matte U
    Cad Saude Publica; 2022; 38(7):e00001022. PubMed ID: 35894360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Streptococcus Pneumoniae Urinary Antigen Testing in Decreasing Mortality of COVID-19 Co-Infected Patients: A Clinical Investigation.
    Desai A; Santonocito OG; Caltagirone G; Kogan M; Ghetti F; Donadoni I; Porro F; Savevski V; Poretti D; Ciccarelli M; Martinelli Boneschi F; Voza A
    Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33138045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality of hospitalized patients with COVID-19: Effects of treatment options (vitamin D, anticoagulation, isoprinosine, ivermectin) assessed by propensity score matching, retrospective analysis.
    Plasek J; Dodulik J; Gai P; Hrstkova B; Skrha J; Zlatohlavek L; Vlasakova R; Danko P; Ondracek P; Cubova E; Capek B; Kollarova M; Furst T; Vaclavik J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2024 Mar; 168(1):35-43. PubMed ID: 38050692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy and clinical outcomes of hospitalized COVID-19 patients in Chile during the first wave of pandemic.
    Muñoz D; Cano C; Amador J; Vergara S; Ruiz G
    Rev Med Chil; 2023 May; 151(5):541-550. PubMed ID: 38687535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia: A retrospective cohort study.
    Russo G; Solimini A; Zuccalà P; Zingaropoli MA; Carraro A; Pasculli P; Perri V; Marocco R; Kertusha B; Del Borgo C; Del Giudice E; Fondaco L; Tieghi T; D'Agostino C; Oliva A; Vullo V; Ciardi MR; Mastroianni CM; Lichtner M
    PLoS One; 2021; 16(9):e0257376. PubMed ID: 34506608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Sivapalan P; Ulrik CS; Bojesen RD; Lapperre TS; Eklöf JV; Håkansson KEJ; Browatzki A; Tidemansen C; Wilcke JT; Janner J; Gottlieb V; Meteran H; Porsbjerg C; Madsen BL; Moberg M; Pedersen L; Benfield TL; Lundgren JD; Knop FK; Biering-Sørensen T; Ghanizada M; Sonne TP; Bødtger UCS; Jensen SG; Rasmussen DB; Brøndum E; Tupper OD; Sørensen SW; Alstrup G; Laursen CB; Møller UW; Sverrild A; Jensen JS
    Trials; 2020 Jun; 21(1):513. PubMed ID: 32522282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection.
    Procter BC; Ross C; Pickard V; Smith E; Hanson C; McCullough PA
    Rev Cardiovasc Med; 2020 Dec; 21(4):611-614. PubMed ID: 33388006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily glucose variation influenced by the use of corticosteroids in COVID-19 patients treated in Lima-Peru.
    Cardoza-Jiménez KJ; Carranza-Zavala B; Manrique-Franco K; Espinoza-Morales F; Mejia CR
    Diabetes Metab Syndr; 2021; 15(4):102188. PubMed ID: 34217143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.